Breaking News Instant updates and real-time market news.

TEVA

Teva

$8.46 /

-0.01 (-0.12%)

09:38
05/25/22
05/25
09:38
05/25/22
09:38

Teva reaches agreement with West Virginia to settle opioid-related claims

Teva Pharmaceuticals has reached an agreement with the Attorney General of West Virginia that settles the state's and its subdivisions opioid-related claims. The settlement will provide West Virginia with $75M over 15 years in addition to $8M in attorneys' fees and costs incurred during the trial. Teva will also provide its life-saving medicine, the generic version of Narcan, valued at $27M over 10 years. The settlement structure is consistent with previously announced settlements. This settlement with the state of West Virginia is another critical step forward in getting life-saving treatments to people suffering from addiction to opioids. This settlement agreement is not an admission of any liability or wrongdoing, and the company continues to actively negotiate a national settlement.

  • 30

    Jun

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Bluegreen Vacations price target lowered to $56 from $57 at Truist » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
BVH

Bluegreen Vacations

$23.67 /

+0.01 (+0.04%)

Truist analyst C. Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BVH Bluegreen Vacations
$23.67 /

+0.01 (+0.04%)

BVH Bluegreen Vacations
$23.67 /

+0.01 (+0.04%)

03/08/22 Truist
Bluegreen Vacations price target raised to $56 from $44 at Truist
11/16/21 Truist
Bluegreen Vacations price target raised to $44 from $41 at Truist
11/05/21 B. Riley
Bluegreen Vacations price target raised to $59 from $42.50 at B. Riley
09/29/21 Truist
Bluegreen Vacations Holding assumed with a Buy at Truist
BVH Bluegreen Vacations
$23.67 /

+0.01 (+0.04%)

Hot Stocks
Rapid Micro Biosystems rejects non-binding proposal from Kennedy Lewis » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

In addition, the Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Downgrade
TIS Inc. downgraded to Neutral from Buy at Citi » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
TISNF

TIS Inc.

/

+

Citi analyst Mitsunobu…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TISNF TIS Inc.
/

+

05/26/22 Jefferies
TIS Inc. downgraded to Hold from Buy at Jefferies
12/14/21 Daiwa
TIS Inc. upgraded to Outperform from Neutral at Daiwa
10/01/21 Credit Suisse
TIS Inc. downgraded to Neutral from Outperform at Credit Suisse
09/17/21 Daiwa
TIS Inc. downgraded to Neutral from Outperform at Daiwa
Recommendations
System1 price target lowered to $13 from $15 at Benchmark » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
SST

System1

$8.69 /

+0.045 (+0.52%)

Benchmark analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

07/11/22 BofA
BofA starts System1 at Buy with $12 price target
07/11/22 BofA
System1 initiated with a Buy at BofA
04/26/22 Evercore ISI
System1 initiated with an In Line at Evercore ISI
04/06/22 DA Davidson
System1 price target raised to $26 from $23 at DA Davidson
SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

Hot Stocks
Iterum Therapeutics expects cash to fund operations into 2024 » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
ITRM

Iterum Therapeutics

$0.25 /

+0.0007 (+0.28%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITRM Iterum Therapeutics
$0.25 /

+0.0007 (+0.28%)

ITRM Iterum Therapeutics
$0.25 /

+0.0007 (+0.28%)

Earnings
Iterum Therapeutics reports Q2 adjusted EPS (3c) vs (4c) last year » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
ITRM

Iterum Therapeutics

$0.25 /

+0.0007 (+0.28%)

"We are excited to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRM Iterum Therapeutics
$0.25 /

+0.0007 (+0.28%)

ITRM Iterum Therapeutics
$0.25 /

+0.0007 (+0.28%)

Earnings
Casi Pharmaceuticals reports Q2 EPS (56c), consensus (64c) » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
CASI

Casi Pharmaceuticals

$3.91 /

+0.91 (+30.33%)

Reports Q2 revenue $8.6M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CASI Casi Pharmaceuticals
$3.91 /

+0.91 (+30.33%)

CASI Casi Pharmaceuticals
$3.91 /

+0.91 (+30.33%)

06/03/22 BTIG
Casi Pharmaceuticals price target adjusted to $21 at BTIG after 1 for 10 split
05/26/22 Oppenheimer
Casi Pharmaceuticals should benefit from Shanghai's reopening, says Oppenheimer
05/13/22 H.C. Wainwright
Casi Pharmaceuticals price target lowered to $3 from $4 at H.C. Wainwright
CASI Casi Pharmaceuticals
$3.91 /

+0.91 (+30.33%)

Hot Stocks
Rapid Micro Biosystems CCO Andy Keys departs » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

In connection with the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Earnings
Fennec reports Q2 EPS (19c), consensus (14c) » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
FENC

Fennec

$6.99 /

+0.07 (+1.01%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FENC Fennec
$6.99 /

+0.07 (+1.01%)

FENC Fennec
$6.99 /

+0.07 (+1.01%)

08/08/22 Craig-Hallum
Fennec assumed with a Buy at Craig-Hallum
12/01/21 Maxim
Fennec price target lowered to $10 from $12 at Maxim
11/30/21 Craig-Hallum
Fennec price target lowered to $14 from $19 at Craig-Hallum
FENC Fennec
$6.99 /

+0.07 (+1.01%)

Hot Stocks
Rapid Micro Biosystems announces restructuring plan with 20% workforce reduction » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

The Company is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Earnings
Leap Therapeutics reports Q2 EPS (15c), consensus (10c) » 07:04
08/12/22
08/12
07:04
08/12/22
07:04
LPTX

Leap Therapeutics

$1.32 /

+0.15 (+12.82%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LPTX Leap Therapeutics
$1.32 /

+0.15 (+12.82%)

LPTX Leap Therapeutics
$1.32 /

+0.15 (+12.82%)

06/06/22 Piper Sandler
Piper says Leap's DKN-01 combo showed 'interesting early signal of activity'
05/27/22 Piper Sandler
Leap Therapeutics price target lowered to $4 from $6 at Piper Sandler
01/23/22 Piper Sandler
Piper ups Leap Therapeutics target to $6 following DKN-01's ASCO GI Update
12/30/21 Mizuho
Mizuho announces top oncology stock picks for 2022
LPTX Leap Therapeutics
$1.32 /

+0.15 (+12.82%)

  • 22
    Sep
Earnings
Rapid Micro Biosystems lowers FY22 revenue view to at least $17M » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

Consensus $28.01M. The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Earnings
Humacyte reports Q2 EPS 35c, consensus (22c) » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
HUMA

Humacyte

$4.38 /

+0.89 (+25.50%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUMA Humacyte
$4.38 /

+0.89 (+25.50%)

HUMA Humacyte
$4.38 /

+0.89 (+25.50%)

07/18/22 BTIG
Humacyte price target lowered to $10 from $12 at BTIG
05/15/22 Piper Sandler
Humacyte downgraded to Underweight from Overweight at Piper Sandler
03/29/22 Piper Sandler
Humacyte price target lowered to $10 from $17 at Piper Sandler
10/29/21 Cowen
Humacyte initiated with an Outperform at Cowen
HUMA Humacyte
$4.38 /

+0.89 (+25.50%)

HUMA Humacyte
$4.38 /

+0.89 (+25.50%)

Earnings
Ocuphire Pharma reports Q2 EPS (25c) vs (52c) last year » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
OCUP

Ocuphire Pharma

$2.76 /

+0.405 (+17.23%)

"Ocuphire has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCUP Ocuphire Pharma
$2.76 /

+0.405 (+17.23%)

OCUP Ocuphire Pharma
$2.76 /

+0.405 (+17.23%)

05/19/22 Alliance Global Partners
Alliance Global Partners says Ocuphire's Nyxol trial run 'remarkable'
11/24/21 H.C. Wainwright
Ocuphire Pharma initiated with a Buy at H.C. Wainwright
10/06/21 Spartan Capital
Ocuphire Pharma initiated with a Buy at Spartan Capital
OCUP Ocuphire Pharma
$2.76 /

+0.405 (+17.23%)

Downgrade
Powszechny Zaklad Ubezpieczen downgraded to Neutral from Buy at Citi » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
PWZYF

Powszechny Zaklad Ubezpieczen

$7.69 /

+ (+0.00%)

Citi analyst Andrzej…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PWZYF Powszechny Zaklad Ubezpieczen
$7.69 /

+ (+0.00%)

06/21/22 JPMorgan
Powszechny Zaklad Ubezpieczen price target lowered to PLN 46.90 at JPMorgan
05/10/22 JPMorgan
PZU price target lowered to PLN 49.25 from PLN 52.75 at JPMorgan
12/14/21 JPMorgan
Powszechny Zaklad Ubezpieczen price target raised to PLN 152.75 at JPMorgan
Earnings
Honest Company sees FY22 revenue growth flat, consensus $318.65M » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
HNST

Honest Company

$3.83 /

+0.005 (+0.13%)

Revenue outlook reflects…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

06/09/22 Loop Capital
Loop Capital cuts Honest Company to Hold amid pressure reported in mass retail
06/09/22 Loop Capital
Honest Company downgraded to Hold from Buy at Loop Capital
05/16/22 Loop Capital
Honest Company price target lowered to $5 from $8 at Loop Capital
03/28/22 Citi
Honest Company shares look 'awfully cheap' after selloff, says Citi
HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

Hot Stocks
Broadridge raises annual dividend 13% to $2.90 from $2.56 per share » 07:02
08/12/22
08/12
07:02
08/12/22
07:02
BR

Broadridge

$169.66 /

-0.745 (-0.44%)

On August 11,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BR Broadridge
$169.66 /

-0.745 (-0.44%)

BR Broadridge
$169.66 /

-0.745 (-0.44%)

08/17/21 JPMorgan
Broadridge price target raised to $197 from $181 at JPMorgan
08/16/21 DA Davidson
Broadridge price target raised to $158 from $152 at DA Davidson
08/13/21 JPMorgan
Broadridge assumed with an Overweight at JPMorgan
BR Broadridge
$169.66 /

-0.745 (-0.44%)

Earnings
Maverix Metals reports Q2 adjusted EPS 3c, consensus 3c » 07:02
08/12/22
08/12
07:02
08/12/22
07:02
MMX

Maverix Metals

$4.06 /

-0.07 (-1.69%)

Reports Q2 revenue $14.2M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMX Maverix Metals
$4.06 /

-0.07 (-1.69%)

MMX Maverix Metals
$4.06 /

-0.07 (-1.69%)

07/20/22 Stifel
Maverix Metals price target lowered to C$8.25 from C$8.75 at Stifel
04/20/22 National Bank
Maverix Metals price target raised to C$7 from C$6.75 at National Bank
04/20/22 Raymond James
Maverix Metals price target raised to C$8.75 from C$8 at Raymond James
01/18/22 Raymond James
Maverix Metals price target lowered to C$8 from C$8.50 at Raymond James
MMX Maverix Metals
$4.06 /

-0.07 (-1.69%)

Earnings
Rapid Micro Biosystems reports Q2 EPS (31c) vs. ($20.01) last year » 07:02
08/12/22
08/12
07:02
08/12/22
07:02
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Earnings
Honest Company reports Q2 EPS (11c), consensus (8c) » 07:02
08/12/22
08/12
07:02
08/12/22
07:02
HNST

Honest Company

$3.83 /

+0.005 (+0.13%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

06/09/22 Loop Capital
Loop Capital cuts Honest Company to Hold amid pressure reported in mass retail
06/09/22 Loop Capital
Honest Company downgraded to Hold from Buy at Loop Capital
05/16/22 Loop Capital
Honest Company price target lowered to $5 from $8 at Loop Capital
03/28/22 Citi
Honest Company shares look 'awfully cheap' after selloff, says Citi
HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

Recommendations
Rivian Automotive's liqudity can last through most of FY23, says Morgan Stanley » 07:02
08/12/22
08/12
07:02
08/12/22
07:02
RIVN

Rivian Automotive

$38.91 /

+1.475 (+3.94%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

06:44 Today Mizuho
Rivian Automotive price target lowered to $65 from $70 at Mizuho
07/18/22 Deutsche Bank
Rivian Automotive price target lowered to $46 from $69 at Deutsche Bank
07/13/22 Canaccord
Rivian Automotive initiated with a Buy at Canaccord
07/08/22 Wedbush
Wedbush ups Rivian target, says story 'starting to turn the corner'
RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

  • 10
    Nov
RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

Earnings
Broadridge sees FY23 adjusted EPS growth 7%-11%, consensus $7.06 » 07:01
08/12/22
08/12
07:01
08/12/22
07:01
BR

Broadridge

$169.66 /

-0.745 (-0.44%)

Sees FY23 recurring…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BR Broadridge
$169.66 /

-0.745 (-0.44%)

BR Broadridge
$169.66 /

-0.745 (-0.44%)

08/17/21 JPMorgan
Broadridge price target raised to $197 from $181 at JPMorgan
08/16/21 DA Davidson
Broadridge price target raised to $158 from $152 at DA Davidson
08/13/21 JPMorgan
Broadridge assumed with an Overweight at JPMorgan
BR Broadridge
$169.66 /

-0.745 (-0.44%)

Earnings
Broadridge reports Q4 adjusted EPS $2.65, consensus $2.62 » 07:00
08/12/22
08/12
07:00
08/12/22
07:00
BR

Broadridge

$169.66 /

-0.745 (-0.44%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BR Broadridge
$169.66 /

-0.745 (-0.44%)

BR Broadridge
$169.66 /

-0.745 (-0.44%)

08/17/21 JPMorgan
Broadridge price target raised to $197 from $181 at JPMorgan
08/16/21 DA Davidson
Broadridge price target raised to $158 from $152 at DA Davidson
08/13/21 JPMorgan
Broadridge assumed with an Overweight at JPMorgan
BR Broadridge
$169.66 /

-0.745 (-0.44%)

Downgrade
Allegiant Travel downgraded to Peer Perform from Outperform at Wolfe Research » 07:00
08/12/22
08/12
07:00
08/12/22
07:00
ALGT

Allegiant Travel

$107.03 /

-0.12 (-0.11%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

08/10/22 Barclays
Allegiant Travel price target lowered to $150 from $180 at Barclays
08/04/22 Deutsche Bank
Allegiant Travel price target lowered to $190 from $245 at Deutsche Bank
07/26/22 Susquehanna
Allegiant Travel negative reveal suggests price sensitivity, says Susquehanna
07/12/22 Susquehanna
Allegiant Travel price target lowered to $140 from $185 at Susquehanna
ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

Recommendations
Illumina price target lowered to $200 from $220 at Citi » 06:59
08/12/22
08/12
06:59
08/12/22
06:59
ILMN

Illumina

$227.64 /

+0.44 (+0.19%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

06:36 Today Baird
Illumina price target lowered to $215 from $306 at Baird
08/11/22 Piper Sandler
Illumina miss 'surprising' given backlog, says Piper Sandler
07/14/22 Canaccord
Illumina merger challenge not reflection of merits, says Canaccord
07/13/22 Piper Sandler
Illumina uncertainty over Grail continues with ruling, says Piper Sandler
ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.